Waverley Pharma Inc.
						WAVE.V
					
					
						TSX
					
				| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 108.00K | 99.90K | 164.00K | 177.10K | 40.30K | 
| Total Receivables | 37.70K | 57.40K | 145.00K | 37.80K | 77.90K | 
| Inventory | 186.90K | 186.90K | 181.70K | 125.40K | -- | 
| Prepaid Expenses | 13.60K | 14.60K | 16.40K | 10.90K | 61.50K | 
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- | 
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- | 
| Other Current Assets | -- | -- | -- | -- | -- | 
| Total Current Assets | 346.20K | 358.80K | 507.20K | 351.20K | 179.80K | 
| 
										 | 
								|||||
| Total Current Assets | 346.20K | 358.80K | 507.20K | 351.20K | 179.80K | 
| Net Property, Plant & Equipment | 172.80K | 178.00K | 183.10K | 188.00K | -- | 
| Long-term Investments | 155.40K | 155.40K | 155.40K | 74.30K | -- | 
| Goodwill | 155.40K | 155.40K | 155.40K | 74.30K | -- | 
| Total Other Intangibles | 257.10K | 266.80K | 276.60K | 562.50K | 193.30K | 
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- | 
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- | 
| Total Other Assets | 83.90K | 97.80K | 299.70K | 142.70K | 159.90K | 
| Total Assets | 1.02M | 1.06M | 1.42M | 1.32M | 532.90K | 
| 
										 | 
								|||||
| Total Accounts Payable | 263.00K | 339.50K | 669.50K | 570.70K | 317.80K | 
| Total Accrued Expenses | -- | -- | -- | 25.60K | 25.30K | 
| Short-term Debt | 2.14M | 1.98M | 1.95M | 2.01M | 1.44M | 
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- | 
| Finance Division Debt Current | 29.70K | 27.80K | 25.80K | 23.60K | -- | 
| Total Finance Division Other Current Liabilities | 6.40K | 4.40K | 33.20K | 24.20K | 26.60K | 
| Total Other Current Liabilities | 6.40K | 4.40K | 33.20K | 24.20K | 26.60K | 
| Total Current Liabilities | 2.44M | 2.35M | 2.68M | 2.65M | 1.81M | 
| 
										 | 
								|||||
| Total Current Liabilities | 2.44M | 2.35M | 2.68M | 2.65M | 1.81M | 
| Long-Term Debt | -- | -- | -- | -- | -- | 
| Short-term Debt | 2.14M | 1.98M | 1.95M | 2.01M | 1.44M | 
| Capital Leases | 141.20K | 146.60K | 152.10K | 157.60K | -- | 
| Finance Division Debt Non Current | -- | -- | -- | -- | -- | 
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- | 
| Total Other Liabilities | -- | -- | -- | -- | -- | 
| Total Liabilities | 2.58M | 2.50M | 2.83M | 2.81M | 1.81M | 
| 
										 | 
								|||||
| Common Stock & APIC | 5.73M | 5.43M | 5.43M | 5.78M | 5.71M | 
| Retained Earnings | -7.63M | -7.22M | -7.19M | -7.61M | -7.31M | 
| Treasury Stock & Other | 336.00K | 347.80K | 348.30K | 333.20K | 329.80K | 
| Total Common Equity | -1.57M | -1.44M | -1.41M | -1.49M | -1.27M | 
| 
										 | 
								|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- | 
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- | 
| Preferred Stock Convertible | -- | -- | -- | -- | -- | 
| Preferred Stock, Others | -- | -- | -- | -- | -- | 
| Total Preferred Equity | -- | -- | -- | -- | -- | 
| 
										 | 
								|||||
| Total Common Equity | -1.57M | -1.44M | -1.41M | -1.49M | -1.27M | 
| Total Preferred Equity | -- | -- | -- | -- | -- | 
| Total Minority Interest | -- | -- | -- | -- | -- | 
| Total Equity | -1.57M | -1.44M | -1.41M | -1.49M | -1.27M | 
| 
										 | 
								|||||